The
outer membrane (OM) of Gram-negative (G−) bacteria presents
a barrier for many classes of antibacterial agents. Lipopolysaccharide
(LPS), present in the outer leaflet of the OM, is stabilized by divalent
cations and is considered to be the major impediment for antibacterial
agent permeation. However, the actual affinities of major antibiotic
classes toward LPS have not yet been determined. In the present work,
we use Langmuir monolayers formed from E. coli Re
and Rd types of LPS to record pressure–area isotherms in the
presence of antimicrobial agents. Our observations suggest three general
types of interactions. First, some antimicrobials demonstrated no
measurable interactions with LPS. This lack of interaction in the
case of cefsulodin, a third-generation cephalosporin antibiotic, correlates
with its low efficacy against G– bacteria. Ampicillin and ciprofloxacin
also show no interactions with LPS, but in contrast to cefsulodin,
both exhibit good efficacy against G– bacteria, indicating
permeation through common porins. Second, we observe substantial intercalation
of the more hydrophobic antibiotics, novobiocin, rifampicin, azithromycin,
and telithromycin, into relaxed LPS monolayers. These largely repartition
back to the subphase with monolayer compression. We find that the
hydrophobic area, charge, and dipole all show correlations with both
the mole fraction of antibiotic retained in the monolayer at the monolayer–bilayer
equivalence pressure and the efficacies of these antibiotics against
G– bacteria. Third, amine-rich gentamicin and the cationic
antimicrobial peptides polymyxin B and colistin show no hydrophobic
insertion but are instead strongly driven into the polar LPS layer
by electrostatic interactions in a pressure-independent manner. Their
intercalation stably increases the area per molecule (by up to 20%),
which indicates massive formation of defects in the LPS layer. These
defects support a self-promoted permeation mechanism of these antibiotics
through the OM, which explains the high efficacy and specificity of
these antimicrobials against G– bacteria.